Plus   Neg

Cambrex Corp. Q4 Profit Tops Estimates; Revenue Up 2.5%

Cambrex Corp. (CBM) reported that its fourth-quarter GAAP EPS from continuing operations increased 4% to $1.20 from $1.15, last year. Adjusted income from continuing operations was $42.4 million or $1.27 per share, compared to $40.8 million or $1.23 per share in the same quarter last year. EBITDA increased to $64.7 million compared to $63.6 million in the same quarter last year. On average, five analysts polled by Thomson Reuters expected the company to report profit per share of $1.12 for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter net revenue increased 2.5% to $182.3 million compared to $177.9 million in the same quarter last year. Excluding the impact of foreign exchange, net revenue increased 1%. Analysts expected revenue of $184.4 million for the quarter.

The company expects 2018 adjusted net revenue, excluding the impact of foreign currency and change in accounting principle, to be between -2% and 2% compared to 2017 and adjusted EBITDA to be between $150 and $160 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT